Clinical Study
Central Precocious Puberty: Treatment with Triptorelin 11.25 mg
Table 2
Biochemical data at baseline and 3, 6, and 12 months of quarterly triptorelin 11.25 mg.
| | baseline | 3 months | 6 months | 12 months |
| Basal LH, IU/L | | | | | Peak LH, IU/L | | | | | Peak LH < 3 IU/L | — | 17/17 | 17/17 | 17/17 | Basal FSH, IU/L | | | | | Peak FSH, IU/L | | | | | 17β estradiol, pmol/L° | | | | | 17β estradiol < 70 pmol/L° | 11/16 | 16/16 | 16/16 | 16/16 |
|
|
°data related to the 16 girls enrolled in the study. °Peak < 2 IU/L 17/47 a M3, M6, M12.
|